Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Failure, Chronic”

360 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 360 results

Early research (Phase 1)Not Yet RecruitingNCT07131540
What this trial is testing

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)

Who this might be right for
Acute-On-Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 10
Not applicableStudy completedNCT03641872
What this trial is testing

A Validation Cohort for ACLF Diagnosis and Prognosis

Who this might be right for
Liver Failure, Acute on ChronicLiver Dysfunction
Hai Li 1,370
Post-approval studies (Phase 4)UnknownNCT03987893
What this trial is testing

PEG3350 in ACLF With Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyAcute-On-Chronic Liver Failure
Post Graduate Institute of Medical Education and Research, Chandigarh 60
Large-scale testing (Phase 3)Study completedNCT03833362
What this trial is testing

Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study)

Who this might be right for
Hepatitis C
R-Pharm 420
Large-scale testing (Phase 3)WithdrawnNCT02806362
What this trial is testing

Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)

Who this might be right for
Chronic Hepatitis C Virus
AbbVie
Testing effectiveness (Phase 2)Study completedNCT01254994
What this trial is testing

The Efficacy and Safety of Entecavir Treatment of Patients With Acute on Chronic Hepatitis B Liver Failure

Who this might be right for
Liver Failure
Sun Yat-sen University 108
Very early researchStudy completedNCT02687763
What this trial is testing

Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant

Who this might be right for
RENAL INSUFFICIENCY, CHRONICLIVER FAILURE, ACUTEHEART DISEASE
Medical University of South Carolina 5
Not applicableUnknownNCT06069037
What this trial is testing

SALT for Treatment of Patients With Early ACLF

Who this might be right for
Acute-On-Chronic Liver Failure
RenJi Hospital 10
Large-scale testing (Phase 3)Ended earlyNCT00364689
What this trial is testing

RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial

Who this might be right for
Hepatic Encephalopathy
University of Miami 13
Not applicableUnknownNCT06224023
What this trial is testing

Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure

Who this might be right for
Ascites HepaticLiver FailureCirrhosis, Liver
Carol Davila University of Medicine and Pharmacy 30
Not applicableEnded earlyNCT01079091
What this trial is testing

Hepa Wash Treatment of Patients With Acute-on-Chronic Liver Failure in Intensive Care Units

Who this might be right for
Acute on Chronic Hepatic Failure
Hepa Wash GmbH 14
Not applicableUnknownNCT06066814
What this trial is testing

To Study the Role of Plasma Von Willebrand Factor Antigen (vWF) to A Disintegrin-like and Metalloproteinase With Thrombospondin Type-1 Motifs 13 (ADAMTS-13) Activity Ratio as a Predictor of Development of Extrahepatic Organ Failure in Acute on Chronic Liver Failure (ACLF) Patients.

Who this might be right for
Acute on Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 50
Post-approval studies (Phase 4)Study completedNCT00474955
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 27
Large-scale testing (Phase 3)Study completedNCT00708500
What this trial is testing

Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 404
Testing effectiveness (Phase 2)Ended earlyNCT01937130
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF

Who this might be right for
Acute on Chronic Hepatic FailureAcute Liver FailureLiver Cirrhosis+1 more
Conatus Pharmaceuticals Inc. 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07694297
What this trial is testing

Phase 2 Study of 500 mg BID NTZ on Top of Standard of Care in Patients With Acute Decompensation of Liver Cirrhosis at High Risk of Progression to Acute-on-Chronic Liver Failure or Established Acute-on-Chronic Liver Failure

Who this might be right for
Acute Decompensation of Liver CirrhosisEstablished Acute-on-Chronic Liver Failure
Genfit 16
Not applicableEnded earlyNCT02215902
What this trial is testing

Safety Study of the Aethlon Hemopurifier

Who this might be right for
End Stage Renal DiseaseHepatitis C Infection
Aethlon Medical Inc. 8
Large-scale testing (Phase 3)Study completedNCT02939989
What this trial is testing

Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study

Who this might be right for
Hepatitis C Virus Infection
AbbVie 33
Not applicableStudy completedNCT00407004
What this trial is testing

Elimination of Albumin-Bound Substances by MARS and Prometheus

Who this might be right for
Liver Failure
Medical University of Graz 10
Large-scale testing (Phase 3)Study completedNCT00985426
What this trial is testing

Comparing Safety and Immunogenicity of HEPLISAV-B® to Engerix-B® in Chronic Kidney Disease (CKD) Patients

Who this might be right for
Chronic Kidney Disease
Dynavax Technologies Corporation 521
Next Page